# The Study of the Pathogenesis and Cognitive Behavioral Group Therapy in Obsessive-Compulsive Disorder

> **NCT02739061** · NA · COMPLETED · sponsor: **Shanghai Mental Health Center** · enrollment: 142 (actual)

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **BEHAVIORAL:** cognitive behavioral group therapy
- **DRUG:** sertraline, fluvoxamine
- **OTHER:** cognitive behavioral group therapy and drug therapy

## Key facts

- **NCT ID:** NCT02739061
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-12
- **Primary completion:** 2017-03-08
- **Final completion:** 2017-07-24
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2020-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02739061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02739061, "The Study of the Pathogenesis and Cognitive Behavioral Group Therapy in Obsessive-Compulsive Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02739061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*